Updates are available Correction dated 2021-06-14
Click to view Correction: https://doi.org/10.1007/s40266-021-00873-3
-
Authors
Pazan, Farhad
Collins, Ronan
Gil, Victor M.
Hanon, Olivier
Hardt, Roland
Hoffmeister, Martin
Monteiro, Pedro
Quinn, Terence J.
Ropers, Dieter
Sergi, Giuseppe
Verheugt, Freek W. A.
Wehling, Martin
- License Information
-
More Information
Article History
First Online: 5 June 2020
Change Date: 14 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40266-021-00873-3
Compliance with Ethical Standards
:
: Open Access funding enabled and organized by Projekt DEAL.
: MW was employed by AstraZeneca R&D, Mölndal, as director of discovery medicine (translational medicine) from 2003 to 2006, while on sabbatical leave from his professorship at the University of Heidelberg. Since returning to this position in January 2007, he has received lecturing and consulting fees from Sanofi-Aventis, Bayer, Berlin-Chemie, Boehringer Ingelheim, Aspen, Novartis, Takeda, Roche, Pfizer, Bristol-Myers, Daichii-Sankyo, Lilly, Otsuka, Novo-Nordisk, Shire and LEO Pharma. FWAV has received honoraria for consulting and presentations from Bayer HealthCare, Boehringer Ingelheim, BMS/Pfizer and Daiichi-Sankyo. RC has received honoraria for consulting and presentations from Bayer HealthCare, Boehringer Ingelheim, BMS/Pfizer and Daiichi-Sankyo. VMG has received honoraria for consulting and presentations from Bayer HealthCare, Boehringer Ingelheim, BMS/Pfizer and Daiichi-Sankyo. TJQ has received research support from BMS/Pfizer alliance. TJQ has received honoraria for giving non-promotional lectures from BMS/Pfizer alliance and Bayer. RH has received lecture fees from Bayer Vital GmbH, BMS, Daichii Sankyo, Novartis, Pfizer, Sanofi MSD Pasteur. DR has received honoraria for consulting from Bayer Vital GmbH, Boehringer Ingelheim and Daiichi-Sankyo. DR has received honoraria for giving non-promotional lectures from BMS/Pfizer alliance, Bayer Vital GmbH, Boehringer Ingelheim and Daiichi-Sankyo. OH received lecturing and consulting fees from Pfizer, Bristol Myers Squibb, Bayer, Novartis, Daiichi Sankyo, Servier, Leo Pharma, Boehringer Ingelheim, Astra Zeneca, Boston Scientific. GS, MH, PM and FP declare that they have no conflict of interest.
